Back

Stem cell function in vivo is supported by an alternative glycolysis endpoint

Kwarteng, E. O.; Li, Y.; Nguyen, D. L.; Agathocleous, M.

2026-04-01 biochemistry
10.64898/2026.03.30.715412 bioRxiv
Show abstract

Carbohydrates are classically catabolized by fermentation or oxidation, a choice that impacts many cellular functions including proliferation. Proliferating cells including somatic stem and progenitor cells are thought to favor fermentation over oxidation, and most proliferating cells in vitro depend on lactate production. However, it has not been tested if fermentation and oxidation are the universal obligatory terminal fates for carbohydrates in vivo because the key enzymes, lactate dehydrogenase (LDH) and pyruvate dehydrogenase (PDH), have not been simultaneously deleted in any cell type. Here we show that both fermentation and oxidation are dispensable for the survival and function of hematopoietic stem cells (HSC). Combined LDHA and LDHB deletion to ablate LDH did not impair HSC function, suggesting that HSCs and rapidly proliferating hematopoietic progenitors surprisingly do not require fermentation. Combined LDHA, LDHB, and PDH deletion abolished both glucose oxidation and fermentation, but did not impair HSC function. Glycolysis was preserved, suggesting the operation of an alternative endpoint. LDH/PDH-deficient HSCs terminated glycolysis through pyruvate export. Pyruvate export by HSCs and progenitors was a physiological response to changing nutrient levels. Quadruple deletion of LDHA/B, PDH, and the pyruvate transporter MCT1 impaired HSC function. This suggested that an essential role of glycolysis termination is not to produce acetyl-CoA or lactate but to remove pyruvate. Therefore, in contrast to classical theories and to in vitro metabolism, carbohydrate metabolism in vivo does not require oxidation or fermentation but can terminate directly in pyruvate export, and this alternative pathway is sufficient to support stem cell function.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
eLife
5422 papers in training set
Top 0.3%
23.0%
2
Nature Communications
4913 papers in training set
Top 17%
10.3%
3
PLOS Biology
408 papers in training set
Top 0.4%
8.6%
4
Cell Reports
1338 papers in training set
Top 7%
6.5%
5
Molecular Cell
308 papers in training set
Top 4%
3.7%
50% of probability mass above
6
Cell Metabolism
49 papers in training set
Top 0.4%
3.7%
7
iScience
1063 papers in training set
Top 8%
2.7%
8
EMBO reports
136 papers in training set
Top 2%
2.1%
9
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 29%
1.9%
10
The EMBO Journal
267 papers in training set
Top 1%
1.9%
11
Blood
67 papers in training set
Top 0.7%
1.9%
12
Journal of Cell Biology
333 papers in training set
Top 2%
1.9%
13
Science Advances
1098 papers in training set
Top 14%
1.9%
14
Haematologica
24 papers in training set
Top 0.3%
1.7%
15
Journal of Experimental Medicine
106 papers in training set
Top 2%
1.4%
16
Blood Advances
54 papers in training set
Top 0.9%
1.3%
17
Nucleic Acids Research
1128 papers in training set
Top 14%
1.1%
18
Journal of Hematology & Oncology
10 papers in training set
Top 0.1%
1.0%
19
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 7%
0.9%
20
Scientific Reports
3102 papers in training set
Top 70%
0.9%
21
Stem Cell Reports
118 papers in training set
Top 0.9%
0.8%
22
PLOS ONE
4510 papers in training set
Top 67%
0.8%
23
Cell Research
49 papers in training set
Top 2%
0.8%
24
Cell
370 papers in training set
Top 16%
0.8%
25
Journal of Biological Chemistry
641 papers in training set
Top 4%
0.8%
26
PLOS Genetics
756 papers in training set
Top 15%
0.7%
27
BMC Biology
248 papers in training set
Top 5%
0.7%
28
Journal of Cell Science
353 papers in training set
Top 3%
0.7%